Polymorphisms and defects in FAT/CD36 transcription and translation alter normal lipid metabolism, producing obesity, metabolic syndrome, atherosclerosis, arterial hypertension, diabetes, cardiomyopathy, Alzheimer’s disease, and multiple sclerosis. This evidence concerns the gene CD36 and metabolic syndrome.